Skip to main content
ReproCELL Incorporated logo

ReproCELL Incorporated — Investor Relations & Filings

Ticker · 4978 ISIN · JP3974770004 LEI · 529900NM7KR32GGRSU46 T Professional, scientific and technical activities
Filings indexed 62 across all filing types
Latest filing 2016-02-12 Interim / Quarterly Rep…
Country JP Japan
Listing T 4978

About ReproCELL Incorporated

https://www.reprocell.com/

ReproCELL Incorporated is a global company providing solutions for preclinical and clinical research, with a primary focus on stem cell technology, drug discovery, and regenerative medicine. The company's portfolio includes a wide range of products such as induced pluripotent stem cells (iPSCs), differentiated cells, 3D cell culture models, and specialized reagents like RNA-based reprogramming kits that avoid genomic integration. ReproCELL also offers extensive contract research services, including human tissue assays for evaluating drug efficacy and safety. A key area of expertise is the GMP-compliant manufacturing of clinical-grade iPSCs and iPSC-derived mesenchymal stem cells (iMSCs), supporting the development of advanced cell therapies. The company's tools and services are designed to help academic and commercial scientists accelerate the translation of research into clinical applications.

Recent filings

Filing Released Lang Actions
四半期報告書-第14期第3四半期(2015/10/01-2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for ReproCELL Incorporated, covering the third quarter of the 14th fiscal period (October 1, 2015, to December 31, 2015). It contains detailed financial statements, management analysis of financial conditions, and business results, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-02-12 Japanese
四半期報告書-第14期第2四半期(2015/07/01-2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for ReproCELL Incorporated, covering the second quarter of the 14th fiscal period (April 1, 2015 to September 30, 2015). It contains detailed financial statements, management analysis of financial conditions, and business results, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2016
2015-11-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.